These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2511344)

  • 1. Visceral leishmaniasis: a seroepidemiological study of 289 children from endemic foci in Azad Jammu and Kashmir by indirect fluorescent antibody technique.
    Rab MA; Iqbal J; Azmi FH; Munir MA; Saleem M
    J Pak Med Assoc; 1989 Sep; 39(9):225-8. PubMed ID: 2511344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological features of childhood visceral leishmaniasis in Azad Jammu & Kashmir Pakistan.
    Altaf C; Ahmed P; Ashraf T; Anwar M; Ahmed I
    J Ayub Med Coll Abbottabad; 2005; 17(4):48-50. PubMed ID: 16599035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leishmania infantum in the Himalayas.
    Rab MA; Evans DA
    Trans R Soc Trop Med Hyg; 1995; 89(1):27-32. PubMed ID: 7747300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Childhood visceral leishmaniasis in Muzaffarabad, Azad Jammu and Kashmir: frequency and response to treatment in 61 cases.
    Altaf C; Ahmed P; Ashraf T; Anwar M; Ahmed I
    J Pak Med Assoc; 2005 Nov; 55(11):475-8. PubMed ID: 16304865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visceral leishmaniasis--a study of 38 cases on the basis of geographical distribution.
    Hassan K; Ikram N; Bukhari KP; Shah SH; Hassan M
    J Pak Med Assoc; 1995 May; 45(5):125-7. PubMed ID: 7563576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of asymptomatic visceral leishmaniasis cases using western blot in an endemic area in Turkey.
    Sakru N; Korkmaz M; Ozbel Y; Ertabaklar H; Sengul M; Toz SO
    New Microbiol; 2007 Jan; 30(1):13-8. PubMed ID: 17319595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Investigation of anti-Leishmania seroprevalence by different serologic assays in children inhabiting in the northwestern part of Turkey].
    Doğan N; Bör O; Dinleyici EC; Töz SO; Ozbel Y
    Mikrobiyol Bul; 2008 Jan; 42(1):103-11. PubMed ID: 18444567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The infection risk of visceral leishmaniasis among household members of active patients.
    Sakru N; Ozensoy Toz S; Korkmaz M; Kavakli T; Alkan MZ; Ozbel Y
    Parasitol Int; 2006 Jun; 55(2):131-3. PubMed ID: 16412686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The burden of the Leishmania chagasi/infantum infection in a closed rural focus of visceral leishmaniasis in Lara state, west-central Venezuela.
    Feliciangeli MD; Delgado O; Suarez B; Chiurillo MA
    Trop Med Int Health; 2005 May; 10(5):444-9. PubMed ID: 15860091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical presentation and management of visceral leishmaniasis.
    Tanoli ZM; Rai ME; Gandapur AS
    J Ayub Med Coll Abbottabad; 2005; 17(4):51-3. PubMed ID: 16599036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous and visceral leishmaniasis in dogs from a rural community in northeastern Brazil.
    Dantas-Torres F; de Paiva-Cavalcanti M; Figueredo LA; Melo MF; da Silva FJ; da Silva AL; Almeida EL; Brandão-Filho SP
    Vet Parasitol; 2010 Jun; 170(3-4):313-7. PubMed ID: 20227186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The diagnosis of visceral leishmaniasis (carried in) (author's transl)].
    Falkner von Sonnenburg F; Krampitz HE; Löscher T; Prüfer L; Weiland G
    MMW Munch Med Wochenschr; 1979 Oct; 121(42):1353-6. PubMed ID: 117316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visceral leishmaniasis in children. A new focus in Azad Kashmir.
    Saleem M; Anwar CM; Malik IA
    J Pak Med Assoc; 1986 Sep; 36(9):230-3. PubMed ID: 3097349
    [No Abstract]   [Full Text] [Related]  

  • 14. Pediatric visceral leishmaniasis in Austria: diagnostic difficulties in a non-endemic region.
    Vécsei AK; Kastner U; Trebo M; Kornmüller R; Picher O; Schratzberger-Vécsei E; Gadner H
    Wien Klin Wochenschr; 2001 Feb; 113(3-4):102-6. PubMed ID: 11253734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visceral leishmaniasis in Somalia. Circulating antibodies as measured by DAT, immunofluorescence and ELISA.
    Shiddo SA; Mohamed AA; Huldt G; Loftenius A; Nilsson L; Jonsson J; Ouchterlony O; Thorstensson R
    Trop Geogr Med; 1995; 47(2):68-73. PubMed ID: 8592766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leishmania tropica-isolated patient with visceral leishmaniasis in southern Iran.
    Alborzi A; Rasouli M; Shamsizadeh A
    Am J Trop Med Hyg; 2006 Feb; 74(2):306-7. PubMed ID: 16474088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
    Lemesre JL; Holzmuller P; Gonçalves RB; Bourdoiseau G; Hugnet C; Cavaleyra M; Papierok G
    Vaccine; 2007 May; 25(21):4223-34. PubMed ID: 17395339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for subclinical Leishmania infection in HIV-infected patients living in eastern Spain.
    Ena J; Pasquau F; del Mar López-Perezagua M; Martinez-Peinado C; Arjona F
    Pathog Glob Health; 2014 Dec; 108(8):356-61. PubMed ID: 25468205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High frequency of asymptomatic Leishmania spp. infection among HIV-infected patients living in endemic areas for visceral leishmaniasis in Brazil.
    Orsini M; Canela JR; Disch J; Maciel F; Greco D; Toledo A; Rabello A
    Trans R Soc Trop Med Hyg; 2012 May; 106(5):283-8. PubMed ID: 22348817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Epidemiological, clinical and biological features of infantile visceral leishmaniasis at Kairouan hospital (Tunisia): about 240 cases].
    Aissi W; Ben Hellel K; Habboul Z; Ben Sghaier I; Harrat Z; Bouratbine A; Aoun K
    Bull Soc Pathol Exot; 2015 Oct; 108(4):265-71. PubMed ID: 26168849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.